FDA Approved: NEVANAC — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved a supplemental NDA for NEVANAC (nepafenac) submitted by Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation After Cataract Surgery
• Postoperative Ocular Pain

Drugs mentioned

• Nevanac (nepafenac)

Snippet

SUPPL AP for NEVANAC (NEPAFENAC)